Tumor-initiating cells are rare in many human tumors.
Tumor-initiating cells (TICs) are defined by their ability to form tumors after xenotransplantation in immunodeficient mice and appear to be relatively rare in most human cancers. Recent data in melanoma indicate that the frequency of TICs increases dramatically via more permissive xenotransplantation conditions, raising the possibility that the true frequency of TICs has been greatly underestimated in most human tumors. We compared the growth of human pancreatic, non-small cell lung, and head and neck carcinomas in NOD/SCID and NSG mice. Although TIC frequency was detected up to 10-fold higher in NSG mice, it remained low (<1 in 2500 cells) in all cases. Moreover, aldehyde dehydrogenase-positive (ALDH(+)) and CD44(+)CD24(+) cells, phenotypically distinct cells enriched in TICs, were equally tumorigenic in NOD/SCID and NSG mice. Our findings demonstrate that TICs are rare in these cancers and that the identification of TICs and their frequency in other human malignancies should be validated via primary tumors and highly permissive xenotransplantation conditions.
Ishizawa
Kota
K
Latner Thoracic Surgery Research Laboratories, Toronto General Research Institute, University of Toronto, University Health Network, Toronto, Ontario MG5 1L7, Canada.
Rasheed
Zeshaan A
ZA
Karisch
Robert
R
Wang
Qiuju
Q
Kowalski
Jeanne
J
Susky
Erica
E
Pereira
Keira
K
Karamboulas
Christina
C
Moghal
Nadeem
N
Rajeshkumar
N V
NV
Hidalgo
Manuel
M
Tsao
Ming
M
Ailles
Laurie
L
Waddell
Thomas K
TK
Maitra
Anirban
A
Neel
Benjamin G
BG
Matsui
William
W
D000818:Animals; D006801:Humans; D051379:Mice; D016513:Mice, SCID; D009369:Neoplasms / Q000209:etiology / Q000473:pathology*; D009374:Neoplasms, Experimental / Q000473:pathology*; D014183:Transplantation, Heterologous
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
17548814
Nature. 1963 Jul 6;199:79-80
14047954
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
12629218
Blood. 2004 Mar 15;103(6):2332-6
14630803
Cancer Res. 2005 Oct 15;65(20):9328-37
16230395
Cancer Res. 2009 Mar 1;69(5):1776-81
19208848
Clin Cancer Res. 2008 Sep 1;14(17):5610-8
18765555
Nature. 1994 Feb 17;367(6464):645-8
7509044
Cancer Res. 2006 Oct 1;66(19):9339-44
16990346
Cell. 2009 Sep 4;138(5):822-9
19737509
Cancer Res. 2007 Feb 1;67(3):1030-7
17283135
Cancer Cell. 2008 Feb;13(2):153-66
18242515
J Immunol. 2006 Sep 1;177(5):3448-60
16920987
J Immunol Methods. 2009 Aug 15;347(1-2):70-8
19567251
Nature. 2008 Dec 4;456(7222):593-8
19052619
Science. 2007 Jul 20;317(5836):337
17641192
J Natl Cancer Inst. 2010 Mar 3;102(5):340-51
20164446
Nature. 2004 Nov 18;432(7015):396-401
15549107
Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):973-8
17210912
Nature. 2010 Jul 1;466(7302):133-7
20596026
Nature. 2008 Jan 17;451(7176):345-9
18202660